27 February 2021 : Database Analysis
Sites and Causes of Infection in Patients with Sepsis-Associated Liver Dysfunction: A Population Study from the Medical Information Mart for Intensive Care III
Jinfeng Lin1BCEF, Chunfeng Gu2CD, Suyan Zhang1B, Lijun Tian1B, Ke Ren1B, Zhilong Cao1B, Xudong Han1AG*DOI: 10.12659/MSM.928928
Med Sci Monit 2021; 27:e928928
Table 7 Subgroup analysis of the effect of pathogen type on the occurrence of SALD.
| Pathogens | Odds ratio (95% CI) | P value |
|---|---|---|
| Coagulase-positive | 0.945 (0.838–1.064) | 0.350 |
| Coagulase-negative | 1.324 (1.177–1.489) | <0.001 |
| 1.287 (1.126–1.471) | <0.001 | |
| Methicillin-resistant | 0.903 (0.713–1.144) | 0.398 |
| 0.879 (0.701–1.103) | 0.265 | |
| species | 0.867 (0.684–1.097) | 0.235 |
| β (group B) | 0.859 (0.534–1.380) | 0.529 |
| Viridans | 1.435 (1.019–2.019) | 0.038 |
| 1.305 (0.867–1.966) | 0.202 | |
| 3.065 (2.344–4.008) | <0.001 | |
| 1.049 (0.708–1.556) | 0.810 | |
| β | 0.798 (0.486–1.31) | 0.372 |
| species | 1.801 (1.235–2.627) | 0.002 |
| α | 0.89 (0.518–1.527) | 0.671 |
| 1.242 (1.077–1.431) | 0.003 | |
| 1.066 (0.902–1.259) | 0.453 | |
| 1.292 (1.087–1.534) | 0.004 | |
| 0.52 (0.348–0.777) | 0.001 | |
| 1.454 (1.119–1.889) | 0.005 | |
| 1.482 (1.076–2.042) | 0.016 | |
| 0.557 (0.341–0.912) | 0.020 | |
| 1.521 (1.126–2.054) | 0.006 | |
| 2.061 (1.522–2.791) | <0.001 | |
| 2.066 (1.511–2.824) | <0.001 | |
| 1.094 (0.72–1.663) | 0.674 | |
| 1.92 (1.297–2.841) | 0.001 | |
| species | 0.625 (0.303–1.288) | 0.203 |
| Yeast | 1.606 (1.441–1.79) | <0.001 |
| 0.485 (0.211–1.116) | 0.089 | |
| 1.616 (1.328–1.967) | <0.001 | |
| 1.793 (1.255–2.563) | 0.001 | |
| 2.144 (1.374–3.347) | 0.001 | |
| Herpes simplex virus type 1 | 1.918 (1.23–2.992) | 0.004 |
| Herpes simplex virus type 2 | 0.65 (0.209–2.025) | 0.457 |
| SALD – sepsis-associated liver dysfunction; CI – confidence interval. | ||






